Company / Profit Margin
Nurix Therapeutics, Inc. Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-314.9%
FY2025
5-year range
-393.9% / -69.7%
FY2021-FY2025
Trend
+11.3%
vs FY2024
Sector context
#116 of 145
Health Care
What the data says
Nurix Therapeutics, Inc.'s profit margin of -314.9% is lower than 80% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 7 years, ranging from -393.9% in FY2022 to -69.7% in FY2021.
Based on SEC 10-K filings.
-314.9% in FY2025 with a 5-year CAGR of -72.2%.
Declined from -187.0% to -314.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +79.0pp
- 5-Year Change
- -72.2pp
- 10-Year Change
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 145This company -314.9% Sector average -792.7%
▼
+60.3% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 11.3% year-over-year.
- Currently 477.8pp above the Health Care sector average.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -314.9% | +11.3% |
| FY2024 | -354.9% | -89.8% |
| FY2023 | -187.0% | +52.5% |
| FY2022 | -393.9% | -464.9% |
| FY2021 | -69.7% | +71.3% |
| FY2020 | -242.7% | -247.9% |
| FY2019 | -69.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026